abstract |
The following formula The disclosed embodiments relate to novel interleukin receptor associated kinase (IRAK) inhibitors and compositions comprising such inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and / or compositions can be used to treat or prevent diseases or conditions associated with IRAK. |